Ms Zulian Liu

Ms Zulian Liu

Institute of Applied Health Research
Honorary Research Fellow

Contact details

Telephone
+44 (0)121 414 8549
Fax
+44 (0)121 414 3759
Email
z.liu@bham.ac.uk
View my research portal
Address
Murray Learning Centre
Institute of Applied Health Research
College of Medical and Dental Sciences
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

Zulian Liu is a Honorary Research Fellow in the Institute of Applied Health Research and currently a Senior Systematic Reviewer at the Nuffield Department of Population Health, University of Oxford.

Zulian has worked in various research capacities, undertaking systematic reviews, rapid evidence reviews and health technology assessments for UK regional and national organisations including the National Institute for Health and Care Excellence (NICE) and the National Institute for Health Research (NIHR) on a wide range of health topics and technologies. 

Qualifications

  • MSc Health Technology Assessment, University of Birmingham, UK 2005
  • Bachelor of Medicine and Bachelor of Surgery, China P.R  1990

Biography

Zulian obtained a MSc in Health Technology Assessment postgraduate degree at the University of Birmingham and has undertaken systematic reviews, rapid evidence reviews and health technology assessments for both regional and national organisations including the National Institute for Health Research (NIHR) and the National Institute for Health and Care Excellence (NICE) on a wide range of topics ranging from pharmaceuticals, interventional procedures, public health and medical technologies. Prior to her UK academic career, Zulian worked as a paediatrician in China. 

Teaching

Zulian teaches research methods to both undergraduate and postgraduate students:

Medicine and Surgery MBChB

Public Health (Health Technology Assessment) MPH/PG Diploma/PG Certificate

Research

  • Systematic reviews
  • Evidence synthesis
  • Health economics
  • Diagnostic accuracy studies
  • Medical technologies
  • Epidemiological studies
  • Evidence based medicine and healthcare

Publications

Zulian Liu, Elaine Kidney, Danai Bem, George Bramley, Sue Bayliss, Mark A de Belder, Carole Cummins, Rui Duarte. Transcatheter aortic valve implantation for aortic stenosis in high surgical risk patients: a systematic review and meta-analysis. PLoS One 2018; In Press.

Richards SH, Anderson L, Jenkinson CE, Whalley B, Rees K, Davies P, Bennett P, Liu Z, West R, Thompson DR, Taylor RS. Psychological interventions for coronary heart disease: Cochrane systematic review and meta-analysis. European Journal of Preventive Cardiolog. 2018;25(3):247-259

Liu Z, Duarte RV, Bayliss S, Bramley G, Cummins C. (2016) Adverse effects of extracorporeal carbon dioxide removal (ECCO2R) for acute respiratory failure: a systematic review protocol. Systematic Reviews 5:98

G Rogers, M Hoyle, J Thompson Coon, T Moxham, Liu Z, Pitt M, K Stein. (2012) Dasatinib and nilotinib for imatinib-resistant or-intolerant chronic myeloid leukaemia: a systematic review and economic evaluation. Health Technology Assessment 16 (22):1366–5278

(22):1366–5278

Hoyle M, Rogers G, Moxham T, Liu Z, Stein K. (2011) Cost-effectiveness of dasatinib and nilotinib for imatinib-resistant or -intolerant chronic phase chronic myeloid leukemia. Value in Health 14(8):1057–1067

Malottki K, Barton P, Tsourapas A, Uthman AO, Liu Z, Routh K, et al. (2011) Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor: a systematic review and economic evaluation. Health Technology Assessment 15(14).

Whalley B, Rees K, Davies P, Bennett P, Ebrahim S, Liu Z, West R, Moxham T, Thompson DR, Taylor RS. (2011) Psychological interventions for coronary heart disease (Review). The Cochrane Library 8:CD002902

Thompson Coon J, Hoyle M, Green C, Liu Z, Welch K, Moxham T, et al. (2010) Bevacizumab, sorafenib tosylate,  sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation. Health Technology Assessment 14(2).

Hoyle M, Green C, Thompson-Coon J, Liu Z, Welch K, Moxham T and Stein K. (2010) Cost effectiveness of sorafenib for second line treatment of advanced renal cell carcinoma. Value in Health 13:55–60.

Hoyle M, Green C, Thompson Coon J, Liu Z, Welch K, 

Moxham T, Stein K. (2010) Cost-effectiveness of temsirolimus for first line treatment of advanced renal cell carcinoma. Value in Health 13(1):61–68.

Thompson Coon J S, Liu Z, Hoyle M, Rogers G, Green C, Moxham T, Welch K, and Stein K. (2010) Reply: SUN vs BEVþIFN in first-line mRCC therapy: no evidence for a statistically significant difference in progression-free survival. British Journal of Cancer 5;102(1):234–235.

Bond M, Mealing S, Anderson R, Elston J, Weiner G, Taylor RS, Hoyle M, Liu Z, Price A, Stein K. (2009) The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults: a systematic review and economic model. Health Technology Assessment 13(44).

Main C, Shepherd J, Anderson R, Rogers G, Thompson-Coon J, Liu Z, Hartwell D, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K and Somerville M. (2008) Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years. Health Technology Assessment 12(20).

Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K and Somerville M. (2008) Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over

. Health Technology Assessment 12(19).

Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z , Taylor RJ, Fry-Smith A, Day E, Lintzeris N, Roberts T, Burls A and Taylor RS . (2007) Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technology Assessment 11(9).

Liu Z, Xiong T, Meads C. (2006) Clinical effectiveness of treatment with hyperbaric oxygen for neonatal hypoxic-ischaemic encephalopathy: systematic review of Chinese literature. British Medical Journal 333:374.

Liu Z, Albon E, Hyde C. The effectiveness and cost effectiveness of immunoglobulin replacement therapy for primary immunodeficiency and chronic lymphocytic leukaemia: A systematic review and economic evaluation.DPHE Report No. 54. ISBN: 07044 25793. Birmingham, UK: West Midlands Health Technology Assessment Collaboration, Department of Public Health and Epidemiology, University of Birmingham; 2005.

View all publications in research portal